Importance of informing patients that weight loss may increase the risk of hypoglycemia in patients with type 2 diabetes mellitus who are being treated with insulin and/or insulin secretagogues (e.g., sulfonylureas)
Regulatory control or oxidative damage
Stger JL, Gijbels MJ, van der Velden S, Manca M, van der Loos CM, Biessen EA, Daemen MJ, Lutgens E, de Winther MP
Deep brain stimulation research: DBS targeting the ventral striatum and internal capsule remains an active area of investigation for severe, refractory OCD, with ongoing trials reporting sustained improvement in select patients
Dont trade one problem for another
Proper medical oversight ensures optimal benefits and minimizes any potential risks